<DOC>
	<DOC>NCT01516749</DOC>
	<brief_summary>This is an open-label, proof-of-concept research study to assess the effectiveness of anakinra in the treatment of patients with hidradenitis suppurativa (HS). The planned intervention is to provide about 6 HS patients with anakinra 100mg daily injections to administer subcutaneously for 8 weeks. Then, the study subjects will be followed for a further 8 weeks to monitor for relapse of HS.</brief_summary>
	<brief_title>Anakinra as a Treatment for Hydradenitis Suppurativa</brief_title>
	<detailed_description />
	<mesh_term>Hidradenitis</mesh_term>
	<mesh_term>Hidradenitis Suppurativa</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>1) Signed informed consent form with Confirmed diagnosis of hidradenitis suppurativa with moderate or severe disease activity 1. Use of the following therapies: Etanercept in the 4 weeks prior to the baseline visit (Day 1) Adalimumab in the 8 weeks prior to the baseline visit (Day 1) Infliximab in the 12 weeks prior to the baseline visit (Day 1) Any other investigational biologics in the 8 weeks prior to the baseline visit (Day 1) Leflunomide in the 4 weeks prior to the baseline visit (Day 1) â€¢ Thalidomide in the 4 weeks prior to the baseline visit (Day 1) Cyclosporine in the 4 weeks prior to the baseline visit (Day 1) I.V. immunoglobulin (I.V. Ig) in the 8 weeks prior to the baseline visit (Day 1) 6Mercaptopurine, azathioprine, cyclophosphamide, or chlorambucil in the 12 weeks prior to the baseline visit (Day 1) Colchicine, dapsone, mycophenolate mofetil &amp; systemic antibiotics in the 3 weeks prior to the baseline visit (Day 1) Corticosteroids "20mg/day or &gt;0.4 mg/kg, whichever applies, in the 1 week prior to the baseline visit (Day 1) 2. history of immunocompromise including HIV infection 3. positive Hep B surface antigen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>hidradenitis suppurativa</keyword>
	<keyword>anakinra</keyword>
</DOC>